# A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine

> **NCT03806595** · PHASE1 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 30 (actual)

## Conditions studied

- Migraine in Children
- Posttraumatic Headache

## Interventions

- **DRUG:** Lidocaine 2% Injectable Solution
- **DRUG:** Normal Saline Flush, 0.9% Injectable Solution

## Key facts

- **NCT ID:** NCT03806595
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-03
- **Primary completion:** 2020-12-03
- **Final completion:** 2020-12-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03806595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03806595, "A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03806595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*